Loeffler L J, Sajadi Z, Hall I H
J Med Chem. 1977 Dec;20(12):1584-8. doi: 10.1021/jm00222a009.
Previously reported work on N-protected activated esters of phenylalanine has been extended to include N-protected vinyl, dibromoethyl, and cyanomethyl esters of several other amino acids. These compounds have been synthesized and evaluated in Ehrlich ascites carcinoma, Walker 256 carcinosarcoma, and and P388 lymphocytic leukemia tests. Among compounds tested were derivatives of tyrosine, tryptophan, glycine, leucine, proline, aspartic acid, glutamic acid, 4-aminobutyric acid, and 6-aminocaproic acid. Compounds of greatest potential interest from this study are N-carbobenzoxyglycine 1,2-dibromoethyl ester and N-carbobenzoxy-L-leucine 1,2-dibromoethyl ester. Both compounds were highly active in Ehrlich ascites test systems (33 mg/kg/day). The glycine derivative was also active in the Walker 256 test (2.5 mg/kg/day. Values for LD50's in mice were 148 mg/kg (0.37 mmol/kg) and 225 mg/kg (0.50 mmol/kg) for glycine and leucine derivatives, respectively; therefore, these compounds do not appear to be toxic at effective dose levels.
先前有关苯丙氨酸N-保护的活性酯的研究工作已经扩展到包括其他几种氨基酸的N-保护的乙烯基酯、二溴乙基酯和氰甲基酯。这些化合物已被合成,并在艾氏腹水癌、Walker 256癌肉瘤和P388淋巴细胞白血病试验中进行了评估。所测试的化合物包括酪氨酸、色氨酸、甘氨酸、亮氨酸、脯氨酸、天冬氨酸、谷氨酸、4-氨基丁酸和6-氨基己酸的衍生物。本研究中最具潜在意义的化合物是N-苄氧羰基甘氨酸1,2-二溴乙酯和N-苄氧羰基-L-亮氨酸1,2-二溴乙酯。这两种化合物在艾氏腹水试验系统中均具有高活性(33毫克/千克/天)。甘氨酸衍生物在Walker 256试验中也具有活性(2.5毫克/千克/天)。甘氨酸和亮氨酸衍生物在小鼠中的半数致死量值分别为148毫克/千克(0.37毫摩尔/千克)和225毫克/千克(0.50毫摩尔/千克);因此,这些化合物在有效剂量水平下似乎没有毒性。